TPO and breast carcinoma: We found that these antibodies bound to TPO in 79% (41 of 52; mAb 18) and 87% (45 of 52; mAb 64) of breast cancer samples, and in 59% (17 of 29; mAb 18) and 63% (19 of 30; mAb 64) of normal breast specimens samples.